Kura Oncology (NASDAQ:KURA) Cut to "Sell" at StockNews.com

StockNews.com cut shares of Kura Oncology (NASDAQ:KURA – Free Report) from a hold rating to a sell rating in a report issued on Monday morning. Other equities analysts also recently issued reports about the company. JMP Securities lifted their target price on Kura Oncology from $22.00 to $32.00 and gave the company a market outperform […]

Related Keywords

Dekabank Deutsche Girozentrale , Thomas James Doyle , Kathleen Ford , Securities Exchange Commission , Jupiter Asset Management Ltd , Kura Oncology Company Profile , Walleye Capital , York Mellon Corp , Kura Oncology Inc , Nasdaq , Charles Schwab Investment Management Inc , Kura Oncology , Free Report , Moderate Buy , Oncology Stock Down , Get Free Report , Exchange Commission , James Doyle , Bank Deutsche Girozentrale , New York Mellon Corp , Schwab Investment Management , Asset Management , Kura Oncology Daily ,